RE:RE:RE:RE:News!snuff133 wrote: Dear Friend;
Attached is a news release announcing a stud of heart valve disease in children. Here is some background:
1. When the valve between the atrium and ventricle is defective it leads to back flow due to incomplete closure (also known as regurgitation). This means the atrium has to work harder to push blood into the ventricle and the ventricle has to work harder to pump blood away from the heart.
2. This true for both the right and left side and can cause heart failure on either side.
4. The VMS+3.0 is uniquely able to accurately and reliably measure size (volume) and ejection fraction for all 4 chambers of the heart and so for the first time, cardiologists can easily measure the function of the atria and ventricles using 2D ultrasound. There is no more need for the hit snd miss use of 3D echo or an arduous MRI procedure, which is not done frequently enough to adequately monitor the heart.
5. The purpose of the study is to allow for sequential frequent assessments of children’s hearts as they grow and the heart also gets bigger. The need here is to see if any of the chambers of the heart is enlarging disproportionately as this is the first sign of valvular disease.
6. It is vitally important the stress on the heart is detected early and the valve corrected before the heart becomes permanently enlarged and damaged. Hence it is important to have frequent 2D echocardiograms and the VMS+3.0 is a gentler way to repeatedly evaluate these children.
Thank you for your continued support and interest as Ventripoint continues its mission to improve heart diagnostics and care for all worldwide and especially for children.
Regards,
Investing in a company that is literally saving children's lives.
Today's news means getting our foot in the door of another top hospital. More exposure for the VMS+3.0.
Which will lead to more studies proving its effectiveness. And more hospitals following suit.